期刊文献+

高精度热灌注系统治疗腹腔恶性肿瘤的应用研究 被引量:3

Application Research of High Precision Hyperthermic Perfusion Intraperitoneal System for Celiac Malignancy Treatment
下载PDF
导出
摘要 目的:研究高精度"BR-TRG-II"型腹腔热灌注治疗系统的总体构成以及在腹腔恶性肿瘤热灌注化疗中的应用。方法:通过介绍该系统的构成,结合对39例典型腹腔假性黏液瘤患者的短期随访,对其治疗有效性和安全性进行评估。结果:该系统具有专业计算机热疗软件、全程动态控制等功能,临床初步应用结果表明,其各项性能完全能达到临床设计要求,尤其对腹膜假性黏液腺瘤治疗效果显著。结论:BR-TRC-II型腹腔热灌注治疗系统能满足临床腹腔热灌注化疗的需要,性能稳定,临床安全性好,在对患者生命指标、腹腔情况监测方面有待加强,同时通过改良,结合物理治疗,时于腹腔假性黏液腺瘤及类似腹腔广泛性肿瘤的治疗意义具有较广阔的临床应用前景。 Objective To study the overall system design principle of high-precision "BR-TRG-Ⅱ"hyperthermic peritoneal perfusion treatment system and its application in abdominal malignant tumor thermal perfusion chemotherapy.Methods By the introduction of system structure,combined with the short-term follow-up of 39 cases with typical peritoneal pseudomyxoma peritonei,the treatment effectiveness and safety were evaluated.Results The system had a professional computer hyperthermia software and the whole dynamic control function,clinical preliminary application results showed that the BR -TRG-Ⅱperformance could fully meet the clinical design requirements,especially the treatment effect for pseudomyxoma peritonei adenoma was significant.Conclusion The BR-TRG-Ⅱsystem can meet the needs of clinical hyperthermic peritoneal perfusion chemotherapy,with stable performance and clinical safety.But the monitoring of patients' life indicators and abdominal situation should be strengthened.Through improvement and combination of physical treatment,the system has a broader clinical significance for abdominal pseudocyst mucinous adenoma and similar extensive abdominal tumor therapy.
出处 《医疗卫生装备》 CAS 2012年第5期74-75,共2页 Chinese Medical Equipment Journal
关键词 热灌注系统 化学疗法 控制系统 循环系统 腹腔恶性肿瘤 腹膜假性黏液瘤 hyperthermic perfusion system chemical treatment control system circulation system abdominal malignant tumor pseudomyxoma peritonei
  • 相关文献

参考文献3

二级参考文献49

  • 1刘玉林,陈宪,张照喜,徐宁.腹膜假性黏液瘤的影像学表现[J].临床放射学杂志,2005,24(1):53-56. 被引量:19
  • 2陈凤媛,徐希岳.原发性腹膜假性粘液瘤──附1例报道和文献复习[J].罕少疾病杂志,2000,7(1):35-37. 被引量:3
  • 3Helm CW, Bristow E, Kusamura S, et al. Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer. J Surg Oncol, 2008,98: 283-290.
  • 4Scaringi S, Kianmanesh R, Sabate JM, et al. Advanced gastric cancer with or without peritoneal earcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single westera center experience. Cancer Surg, 2008,34: 1246-1252.
  • 5Giorgio D, Naticcioni E, Biacchi D, et al. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. Am Cancer Soc, 2008, 113: 315-325.
  • 6Elias D, Lefevre JH, Chevalier J, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. Clin Onc, 2009, 27: 681-685.
  • 7Hagendoorn J, Lammeren GV, Boerma D, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal eareinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival. EJSO, 2009, 35: 833-837.
  • 8Baratti D, Kusamura S, Nonaka D, et al. Pseudomyxoma peritonei biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann of Surg, 2009,249: 243-249.
  • 9Baratti D, Kusamura S, Nonaka D, et al. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol, 2007,15: 526-534.
  • 10[1]Sugarbaker PH.Peritoneal carcinomatosis:natural history and rational therapeutic interventions using intraperitoneal chemotherapy.Cancer Treat Res 1996; 81:149-168

共引文献26

同被引文献23

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部